Product Description

Febuxostat 80 mg is a pharmaceutical formulation developed for the effective management of hyperuricemia and gout under medical supervision. The formulation is designed to help lower elevated uric acid levels in the blood, reducing the risk of uric acid crystal formation and supporting long-term gout management. It plays an important role in helping patients maintain joint health and improve quality of life.

Gout is a metabolic condition caused by excessive accumulation of uric acid in the body, leading to the formation of urate crystals in joints and surrounding tissues. This may result in symptoms such as severe joint pain, swelling, redness, inflammation, and reduced mobility. Long-term control of uric acid levels is essential for preventing recurrent gout attacks and minimizing complications associated with chronic hyperuricemia.

Febuxostat belongs to a class of medicines known as xanthine oxidase inhibitors. It works by selectively inhibiting the enzyme responsible for uric acid production in the body. By reducing uric acid formation, Febuxostat helps maintain healthy uric acid levels and decreases the likelihood of crystal deposition in joints and tissues.

The formulation is commonly prescribed as part of long-term gout management programs and may help reduce the frequency of gout flare-ups when used consistently under medical supervision. It supports effective uric acid control and contributes to improved joint comfort and overall patient well-being.

Manufactured under stringent WHO-GMP quality standards, the formulation is produced using advanced pharmaceutical technologies and undergoes comprehensive quality testing to ensure safety, efficacy, purity, and pharmaceutical consistency. Every batch is carefully monitored to maintain dependable therapeutic performance and high-quality healthcare standards.

Key Features

• Supports management of hyperuricemia and gout
• Helps maintain healthy uric acid levels
• Reduces uric acid production in the body
• Supports long-term joint health management
• Reliable and consistent therapeutic performance
• Manufactured under strict WHO-GMP standards
• Produced using advanced pharmaceutical processes

Uses

• Hyperuricemia management
• Gout treatment support
• Long-term uric acid control
• Prevention of recurrent gout attacks under medical supervision

How It Works

Febuxostat works by inhibiting xanthine oxidase, an enzyme involved in uric acid production. This action helps reduce uric acid levels in the bloodstream and supports the prevention of urate crystal formation.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Joint pain
• Skin rash
• Dizziness
• Mild liver function changes
• Diarrhea

Patients should seek immediate medical attention if severe allergic reactions, chest pain, breathing difficulties, or unusual symptoms occur.

Precautions

• Use only under medical supervision
• Regular monitoring of uric acid levels may be recommended
• Inform your doctor about liver, kidney, or cardiovascular conditions
• Avoid self-medication or dosage adjustments without medical advice
• Inform your healthcare provider about all ongoing medications

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured in WHO-GMP certified facilities, the formulation undergoes stringent quality control procedures and comprehensive testing to ensure safety, efficacy, purity, and dependable therapeutic performance. Each batch is evaluated according to international pharmaceutical standards to maintain consistent quality and reliable patient outcomes.